MIS18A: A Potential Drug Target and Biomarker (G54069)

Target Name: MIS18A

NCBI ID: G54069

MIS18A

MIS18A: A Potential Drug Target and Biomarker

MIS18A, also known as MIS18A-ASP2, is a protein that is expressed in various tissues, including the brain, heart, and kidneys, and is involved in the regulation of cellular processes that are critical for human health. Several studies have suggested that MIS18A may have potential as a drug target or biomarker, and further research is needed to determine its full potential.

The MIS18A gene was identified in 2007 and is located on chromosome 6p21. It is a member of the MIM (Mutations in Immediate Genes) family, which is known for encoding proteins that are involved in a variety of cellular processes, including DNA damage repair, cellular signaling, and inflammation. MIS18A is a 21-kDa protein that contains 115 amino acid residues.

Several studies have suggested that MIS18A may have potential as a drug target or biomarker. For example, MIS18A has been shown to be involved in the regulation of cellular processes that are critical for human health, including cell division, apoptosis (programmed cell death), and inflammation. It has also been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the potential reasons for the potential drug target status of MIS18A is its involvement in the regulation of cellular signaling pathways. MIS18A has been shown to be involved in a variety of signaling pathways, including the PI3K/Akt signaling pathway, which is involved in the regulation of cellular processes that are critical for human health. This suggests that MIS18A may be a useful target for drugs that are designed to modulate these signaling pathways and improve cellular health.

Another potential reason for the potential drug target status of MIS18A is its involvement in the regulation of cell division. MIS18A has been shown to be involved in the regulation of cell division, and it has been shown to play a role in the development and progression of various diseases, including cancer. This suggests that MIS18A may be a useful target for drugs that are designed to inhibit cell division and prevent the development of cancer.

In addition to its potential as a drug target, MIS18A has also been suggested as a potential biomarker. Several studies have shown that MIS18A is expressed in various tissues and that it is involved in the regulation of cellular processes that are critical for human health. This suggests that MIS18A may be a useful biomarker for the diagnosis and prognosis of various diseases.

While more research is needed to fully determine the potential of MIS18A as a drug target or biomarker, it is clear that MIS18A is a protein that is involved in a variety of cellular processes that are critical for human health. Further research is needed to fully understand the potential of MIS18A as a drug target or biomarker, and to determine the best way to use it for the benefit of human health.

Protein Name: MIS18 Kinetochore Protein A

Functions: Required for recruitment of CENPA to centromeres and normal chromosome segregation during mitosis

The "MIS18A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIS18A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets